Epidemiological monitoring survey to assess the impact of mass drug administration with triple-drug regimen in lymphatic filariasis elimination programme in an endemic district in Southern India.

Background: Mass Drug Administration (MDA) with triple-drug regimen (Ivermectin, Diethylcarbamazine, and Albendazole- IDA), recommended by the World Health Organization (WHO) was introduced in India in 2018, as an alternate strategy to two drug regimens (Diethylcarbamazine, and Albendazole- DA), for accelerating lymphatic filariasis (LF) elimination. By December 2023, IDA-MDA has been implemented in 63 LF endemic districts in India. The currently followed monitoring and evaluation (M&E) guidelines for DA may not be suitable to this new strategy.

Evaluation of sampling strategies for assessing lymphatic filariasis endemic status of a non-MDA district in South India.

Background: India is moving towards the Lymphatic Filariasis (LF) elimination goal in 2027. Documentation on LF transmission status in the non-endemic and unsurveyed areas is crucial for WHO to certify that LF has been eliminated as a public health problem in the country. Appropriate sampling strategy is necessary to determine LF transmission status in the areas not under mass drug administration (MDA).

Effects of the COVID-19 Pandemic on the Lifestyle and Mental Health of Children in the Puducherry District: A Community-Based Cross-Sectional Study.

Introduction: The COVID-19 pandemic has tremendously disrupted societal behaviors and norms. People had to cope with new situations, including restrictions on free movement, home confinement, and school closures, among others. With less scope for physical classes, online classes became rampantly common during and after the pandemic.